Renol Polychem Complete Financial Statements

RNPL • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2025 - 2024

Complete Financial Data Export

Export complete financial statements for Renol Polychem (RNPL). Downloads include all available records across all periods. For market performance, see the RNPL stock price today .

Profitability Ratios

Net Profit Margin 7.94% 2025 data
EBITDA Margin 11.11% 2025 data
Operating Margin 11.00% 2025 data
Return on Assets 21.74% 2025 data
Return on Equity 38.46% 2025 data

Balance Sheet Ratios

Debt to Equity 1.77 2025 data
Equity Ratio 56.52% 2025 data
Asset Turnover 2.74 2025 data

Year-over-Year Growth Analysis

Comparing March 2025 vs Period
Revenue Growth
-54.0%
Year-over-Year
Net Profit Growth
-60.0%
Year-over-Year
EBITDA Growth
-57.1%
Year-over-Year
Expense Growth
-52.7%
Year-over-Year
Assets Growth
+43.8%
Year-over-Year
Equity Growth
+44.4%
Year-over-Year
Liabilities Growth
+43.8%
Year-over-Year
Operating Cash Flow Growth
-200.0%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2025 March 2024
Revenue 29 63 7
Expenses 26 55 4
EBITDA 3 7 2
Operating Profit Margin % 5.00% 11.00% 35.00%
Depreciation 0 0 0
Interest 0 1 0
Profit Before Tax 3 7 2
Tax 1 2 1
Net Profit 2 5 2
Earnings Per Share (₹) 4.00 9.10 2.79

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 23 16
Current Assets 22 15
Fixed Assets 0 0
Capital Work in Progress 0 0
Investments 0 0
Other Assets 23 15
LIABILITIES
Total Liabilities 23 16
Current Liabilities 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 13 9
Share Capital 6 6
Reserves & Surplus 8 3

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities -1 1
Investing Activities 0 0
Financing Activities 4 0
Net Cash Flow 2 1